Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation
International Journal of Rheumatology · 2015-01 · 2015 (1)
DOI: 10.1155/2015/178750 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatology, online erschienen am 17.12.2015. Verfasst von Mohammed Hammoudeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hamad Medical Corporation, Department of Medicine, Doha, Qatar. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Data on spondyloarthritis (SpA) from the Middle East are sparse and the management of these diseases in this area of the world faces a number of challenges, including the relevant resources to enable early diagnosis and referral and sufficient funds to aid the most appropriate treatment strategy. The objective was to report on the characteristics, disease burden, and treatment of SpA in the Middle East region and to highlight where management strategies could be improved, with the overall aim of achieving better patient outcomes. This multicenter, observational, cross‐sectional study collected demographic, clinical, laboratory, and treatment data on 169 consecutive SpA patients at four centers (Egypt, Kuwait, Qatar, and Saudi Arabia). The data collected presents the average time from symptom onset to diagnosis along with the presence of comorbidities in the region and comparisons between treatment with NSAIDs and biologics. In the absence of regional registries of SpA patients, the data presented here provide a rare snapshot of the characteristics, disease burden, and treatment of these patients, highlighting the management challenges in the region.
Autor:innen und Institutionen
- Hamad Medical Corporation, Department of Medicine, Doha, Qatar.
- Prince Sultan Military Medical Center, P.O. Box 5004, Riyadh 11422, Saudi Arabia.
- Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, 13110 Al-Safat, Kuwait.
- Rheumatology and Immunology Unit, Internal Medicine Department, Cairo University, Cairo 11562, Egypt.
- Pfizer Inc. Africa & Middle East, Dubai, UAE.
- Oregon Health & Science University, Portland, OR 97239, USA.
ORCID-Profile: Adel Alawadhi
Zitieren
APA
Hammoudeh, M., Al Rayes, H., Alawadhi, A., Gado, K., Shirazy, K., & Deodhar, A. (2015). Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation. International Journal of Rheumatology, 2015(1). https://doi.org/10.1155/2015/178750
Vancouver
Hammoudeh M, Al Rayes H, Alawadhi A, Gado K, Shirazy K, Deodhar A. Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation. International Journal of Rheumatology. 2015;2015(1). doi:10.1155/2015/178750
BibTeX
@article{Hammoudeh2015,
author = {Hammoudeh, Mohammed and Al Rayes, Hanan and Alawadhi, Adel and Gado, Kamel and Shirazy, Khalid and Deodhar, Atul},
title = {Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation},
journal = {International Journal of Rheumatology},
year = {2015},
volume = {2015},
number = {1},
doi = {10.1155/2015/178750}
}
EUVIMED